Navigation Links
Unisone Sues Life Technologies Over IP Infringement
Date:6/4/2013

DEL MAR, Calif., June 4, 2013 /PRNewswire/ -- Unisone Strategic IP, Inc. announced June 3, 2013 it has filed a complaint for patent infringement against Life Technologies Corporation in the United States District Court for the Southern District of California, Case No. 13-cv-1278-GPC-JMA.  The complaint alleges that Life Technologies' supply chain management system software infringes on Unisone's U.S. Patent No. 6,996,538, which is directed to inventory control systems and methods.  Unisone is an intellectual property holding company based in San Diego, CA with a patent portfolio spanning 32 countries and serving an international customer base that includes Fortune 100 companies.  Unisone provides its customers with supply chain management software and solutions that give businesses the ability to track, manage, monitor and search inventory in real-time.  Unisone also holds equity positions in several software companies that specialize in these areas, including TradeMotion, LLC and Frequentz, LLC.

Unisone is represented by San Diego IP Law Group, LLP.  Unisone is confident about the merits of its lawsuit and intends to pursue the matter vigorously.

Any inquiries can be directed to James Fazio, III at San Diego IP Law Group at 858.792.3446.


'/>"/>
SOURCE Unisone Strategic IP, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Davron Technologies Beats the Post-recession Odds with Four Years of Net Growth
2. The Renewable Corporation (RNWB) through its wholly owned subsidiary EcoSmart Surface & Coating Technologies receives results from Product Test Service.
3. Biodetection Technologies 2013 and Oak Ridge National Lab’s Biosurveillance Symposium to Bring Together Leading Organizations in Alexandria, VA from June 17-19, 2013
4. Dr. Gerald Jerry Zon Launches New Blog for TriLink BioTechnologies
5. Aridis Pharmaceuticals Announces Acquisition of Monoclonal Antibody Products and Technologies From Kenta Biotech
6. Palatin Technologies Announces Third Quarter Fiscal Year 2013 Results and Update on Development of Bremelanotide for Female Sexual Dysfunction
7. TriLink BioTechnologies Announces Worldwide License with QuantiBact A/S, Copenhagen, Denmark
8. Adaptive Biotechnologies Signs Biomarker Discovery Collaboration Agreement with Bristol-Myers Squibb
9. Palatin Technologies, Inc. To Report Fiscal Year 2013 Third Quarter Results; Teleconference and Webcast to be held on May 14, 2013
10. Lorain County Community College, Austen BioInnovation Institute Join to Advance Medical Technologies
11. Life Technologies Announces First Quarter 2013 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... October 11, 2017 , ... Disappearing forests and increased emissions are ... 5.5 million people each year. Especially those living in larger cities are affected by ... in one of the most pollution-affected countries globally - decided to take action. , ...
(Date:10/10/2017)... (PRWEB) , ... October 10, ... ... development-stage cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed ... targeted HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed in collaboration with ...
(Date:10/10/2017)... Calif. , Oct. 10, 2017 SomaGenics ... from the NIH to develop RealSeq®-SC (Single Cell), expected ... for profiling small RNAs (including microRNAs) from single cells ... Program highlights the need to accelerate development of approaches ... "New techniques for measuring levels ...
(Date:10/9/2017)... ... ... The award-winning American Farmer television series will feature 3 Bar Biologics in an ... on RFD-TV. , With global population estimates nearing ten billion people by 2050, ... a growing nation. At the same time, many of our valuable resources are becoming ...
Breaking Biology Technology:
(Date:4/3/2017)... 3, 2017  Data captured by IsoCode, ... detected a statistically significant association between the ... treatment and objective response of cancer patients ... predict whether cancer patients will respond to ... well as to improve both pre-infusion potency testing ...
(Date:3/29/2017)... , March 29, 2017  higi, the health ... in North America , today announced ... and the acquisition of EveryMove. The new investment and ... set of tools to transform population health activities through ... lifestyle data. higi collects and secures data ...
(Date:3/24/2017)... Research and Markets has announced the addition of the ... Forecast to 2025" report to their offering. ... The Global Biometric Vehicle Access System ... over the next decade to reach approximately $1,580 million by 2025. ... forecasts for all the given segments on global as well as ...
Breaking Biology News(10 mins):